Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

[1]  K. Lindor,et al.  Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  J. Woodcock,et al.  Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using "Real-World" Data. , 2017, JAMA.

[3]  L. Eusebi,et al.  Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. , 2017, The Cochrane database of systematic reviews.

[4]  I. Mackay,et al.  Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis , 2016, Scientific Reports.

[5]  Hwa Young Choi,et al.  Population‐based epidemiology of primary biliary cirrhosis in South Korea , 2016, Alimentary pharmacology & therapeutics.

[6]  J. Sekhon,et al.  A comparison of alternative strategies for choosing control populations in observational studies , 2015, Health Services and Outcomes Research Methodology.

[7]  A. Burroughs,et al.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. , 2014, Gastroenterology.

[8]  C. Ponsioen,et al.  Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[9]  N. Speybroeck.  Classification and regression trees , 2012, International Journal of Public Health.

[10]  O. Chazouilleres,et al.  Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. , 2011, Journal of hepatology.

[11]  Chin-Shang Li,et al.  The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population , 2011, BMC gastroenterology.

[12]  H. Quan,et al.  Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population‐based study , 2009, Hepatology.

[13]  E. Björnsson,et al.  The AST/ALT ratio as an indicator of cirrhosis in patients with PBC , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[14]  T. Therneau,et al.  Epidemiology and natural history of primary biliary cirrhosis in a US community. , 2000, Gastroenterology.

[15]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[16]  T. Therneau,et al.  Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. , 1996, Gastroenterology.

[17]  K. Lindor,et al.  University of Birmingham Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy , 2022 .